Synovics Pharmaceuticals, Inc. (SYVC) Research

Synovics Pharmaceuticals, Inc. operates primarily within the United States, where it, through its various subsidiary entities, specializes in the development, manufacturing, and commercialization of both generic over-the-counter (OTC) and generic prescription pharmaceutical products. Its diverse range of OTC offerings includes common remedies such as pain relievers (analgesics), medications for coughs and colds, antihistamines, treatments for asthma relief, and laxatives. The company handles the packaging and subsequent distribution of these products to major chain drug stores, wholesalers, and other distributors across the U.S. Established in 1983, the firm was initially known as Bionutrics Inc. before officially changing its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. is headquartered in Fort Lauderdale, Florida, and functions as a subsidiary of Maneesh Pharmaceuticals Limited.

Open Synovics Pharmaceuticals, Inc. (SYVC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.